LINEZOLID ESTABILIDAD PDF

The treatment of persistently positive blood cultures in the setting of indwelling central venous catheter CVC -related bacteremia may represent a difficult task when CVC removal is not feasible. In this setting, antibiotic lock has been demonstrated to be an effective option, both as a first-line and as a rescue treatment 3 , 5 , but CVC removal probably remains the treatment of choice. However, this procedure may not always be possible in patients in life-threatening clinical condition or with limited vascular sites, like infants, especially if requiring life-long total parenteral nutrition, or in the presence of conditions that makes catheter withdrawal impossible or at least very difficult. We used linezolid as systemic and lock therapy for the treatment of CVC-related Staphylococcus epidermidis bloodstream infection not responding to other treatments and with clinical conditions that precluded catheter removal. The patient, a 4-year-old girl affected with cystic fibrosis and short-bowel syndrome requiring a Broviac catheter for daily parenteral nutrition, had CVC-related bacteremia due to oxacillin-resistant S.

Author:Mall Vozshura
Country:Mongolia
Language:English (Spanish)
Genre:Video
Published (Last):3 December 2004
Pages:492
PDF File Size:19.38 Mb
ePub File Size:10.18 Mb
ISBN:722-2-71980-386-6
Downloads:67537
Price:Free* [*Free Regsitration Required]
Uploader:Fer



The treatment of persistently positive blood cultures in the setting of indwelling central venous catheter CVC -related bacteremia may represent a difficult task when CVC removal is not feasible. In this setting, antibiotic lock has been demonstrated to be an effective option, both as a first-line and as a rescue treatment 3 , 5 , but CVC removal probably remains the treatment of choice. However, this procedure may not always be possible in patients in life-threatening clinical condition or with limited vascular sites, like infants, especially if requiring life-long total parenteral nutrition, or in the presence of conditions that makes catheter withdrawal impossible or at least very difficult.

We used linezolid as systemic and lock therapy for the treatment of CVC-related Staphylococcus epidermidis bloodstream infection not responding to other treatments and with clinical conditions that precluded catheter removal. The patient, a 4-year-old girl affected with cystic fibrosis and short-bowel syndrome requiring a Broviac catheter for daily parenteral nutrition, had CVC-related bacteremia due to oxacillin-resistant S. In spite of this new treatment, blood cultures remained positive.

Catheter removal was not feasible, unless to perform an extremely invasive cardiovascular surgical procedure, since the patient had an extended thrombosis of the veins that involved the catheter and locked the device to the blood vessels. No signs of cardiac vegetation were present. The idea of this therapeutic procedure stemmed from the observation that very high concentrations of linezolid, achievable by means of catheter lock, were effective in two experimental models of CVC-related staphylococcal infections 1 , 2.

The lock time was shorter than that reported in these studies, since the patient needed daily parenteral nutrition that could not be administered for less than 12 h. Blood cultures were negative after the second day of treatment. Linezolid lock associated with systemic infusion was continued for a total of 20 days without any adverse event. Blood cultures performed daily during this period remained always negative. Three weeks after the end of treatment, blood cultures were still negative and the patient was alive and had the CVC still in place.

Susceptibility pattern of S. Catheter removal represents the treatment of choice for persistent CVC-related bacteremia 3. However, in the presence of clinical conditions that contraindicate this procedure, CVC lock with linezolid may represent a possible treatment option for gram-positive infections when other, more standardized, therapies have failed.

National Center for Biotechnology Information , U. Journal List Antimicrob Agents Chemother v. Antimicrob Agents Chemother. Paolo Gandullia Gastroenterology Unit. Mauro Oddone Service of Radiology. Cristiano Peri Laboratory of Microbiology. Gaslini Children's Hospital Largo G. Gaslini, 5 Genoa , Italy. Author information Copyright and License information Disclaimer.

This article has been cited by other articles in PMC. TABLE 1. Open in a separate window. Curtin, J. Cormican, G. Fleming, J. Keelehan, and E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Agents Chemother. Giacometti, A. Cirioni, R. Ghiselli, F. Orlando, F. Mocchegiani, C. Silvestri, A.

Licci, M. De Fusco, M. Provinciali, V. Saba, and G. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.

Mermel, L. Farr, R. Sheretz, I. Raad, N. O'Grady, J. Harris, and D. Guidelines for the management of intravascular catheter-related infections. Michelow, I. McCracken, Jr. Antibacterial therapeutic agents, p. Feigin, J. Cherry, G. Demmler, and S. Kaplan, ed. The W. Saunders Co. Rijnders, B. Van Wijngaerden, S. Vandecasteele, M. Stas, and W. Treatment of long-term intravascular catheter-related bacteremia with antibiotic lock: randomized, placebo-controlled trial. Stalker, D.

Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Support Center Support Center. External link. Please review our privacy policy.

DIGITAL COMMUNICATION BY J.S.CHITODE PDF

Purchase zyvox side

.

DIE PHILOSOPHISCHE HINTERTREPPE PDF

.

DIN 6701-2 PDF

.

Related Articles